Xinde Hu

Dr. Xinde Hu, received a bachelor's degree from Northwest A&F University and a doctorate from the Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences. In 2020, he was selected into the Shanghai " Outstanding Youth" program. He is currently the Vice President of Shanghai Genemagic Biotechnology Co., Ltd. (VP). He has 11 years of research experience in gene therapy, AAV biology, and treatment of nervous system diseases. A number of Dr Hu’ works have been published in top journals, such as Cell, Nature, Nature Neuroscience, Molecular Therapy, and Cell Research, and a total of more than 30 research works have been published.